Technical Analysis for FRES - Fresh2 Group Limited

Grade Last Price % Change Price Change
D 0.42 -10.64% -0.05
FRES closed up 20.82 percent on Tuesday, April 23, 2024, on 1.39 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish -10.64%
Crossed Above 50 DMA Bullish -10.64%
180 Bullish Setup Bullish Swing Setup -10.64%
Expansion Pivot Buy Setup Bullish Swing Setup -10.64%
Pocket Pivot Bullish Swing Setup -10.64%
Outside Day Range Expansion -10.64%
Wide Bands Range Expansion -10.64%
Up 3 Days in a Row Strength -10.64%
Oversold Stochastic Weakness -10.64%
Shooting Star Candlestick Bearish 7.97%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 2 hours ago
Possible Inside Day about 2 hours ago
20 DMA Support about 4 hours ago
60 Minute Opening Range Breakout about 4 hours ago
Gap Down Partially Closed about 5 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Fresh2 Group Limited is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2023. With two certified clinical laboratories in China and one CLIA and CAP accredited clinical laboratory in the United States, Fresh2 performs a suite of cancer screening and detection tests, including CDA (Cancer Differentiation Analysis), bio-chemical, immunological, and genomics tests. The Company is entering the business-to-business e-commerce food business with the formation of its wholly-owned subsidiary Fresh2 Technology Inc and the acquisition of Fresh2 Ecommerce Inc.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Chemical E Commerce Genomics Medical Laboratory Cancer Screening Science

Is FRES a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.17
52 Week Low 0.2999
Average Volume 193,939
200-Day Moving Average 1.31
50-Day Moving Average 0.44
20-Day Moving Average 0.44
10-Day Moving Average 0.38
Average True Range 0.08
RSI (14) 53.05
ADX 13.03
+DI 21.02
-DI 15.20
Chandelier Exit (Long, 3 ATRs) 0.58
Chandelier Exit (Short, 3 ATRs) 0.57
Upper Bollinger Bands 0.60
Lower Bollinger Band 0.28
Percent B (%b) 0.58
BandWidth 72.91
MACD Line -0.03
MACD Signal Line -0.03
MACD Histogram -0.0028
Fundamentals Value
Market Cap 11.15 Million
Num Shares 23.7 Million
EPS -7.38
Price-to-Earnings (P/E) Ratio -0.06
Price-to-Sales 0.46
Price-to-Book 0.62
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.61
Resistance 3 (R3) 0.59 0.53 0.59
Resistance 2 (R2) 0.53 0.50 0.54 0.58
Resistance 1 (R1) 0.50 0.47 0.52 0.52 0.57
Pivot Point 0.44 0.44 0.45 0.45 0.44
Support 1 (S1) 0.41 0.40 0.42 0.42 0.37
Support 2 (S2) 0.35 0.38 0.35 0.36
Support 3 (S3) 0.32 0.35 0.35
Support 4 (S4) 0.33